Carl‐Martin Kirsch

3.6k total citations · 1 hit paper
59 papers, 2.8k citations indexed

About

Carl‐Martin Kirsch is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Carl‐Martin Kirsch has authored 59 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Radiology, Nuclear Medicine and Imaging, 20 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Carl‐Martin Kirsch's work include Medical Imaging Techniques and Applications (25 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). Carl‐Martin Kirsch is often cited by papers focused on Medical Imaging Techniques and Applications (25 papers), Lung Cancer Diagnosis and Treatment (15 papers) and Radiopharmaceutical Chemistry and Applications (13 papers). Carl‐Martin Kirsch collaborates with scholars based in Germany, United States and France. Carl‐Martin Kirsch's co-authors include D. Hellwig, Ursula Nestle, Stephanie Kremp, Christian Rübe, Andrea Schaefer, Andrea Schaefer-Schuler, Christof Alexander, Samuel Samnick, Jochen B. Bader and Hans‐Joachim Schäfers and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Brain.

In The Last Decade

Carl‐Martin Kirsch

59 papers receiving 2.7k citations

Hit Papers

Comparison of different methods for delineation of 18F-FD... 2005 2026 2012 2019 2005 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer.
    2005 503 citations Ursula Nestle, Stephanie Kremp et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl‐Martin Kirsch Germany 26 1.5k 1.0k 533 348 335 59 2.8k
Tohru Shiga Japan 32 1.7k 1.1× 905 0.9× 644 1.2× 213 0.6× 311 0.9× 181 3.7k
Hugo W. A. M. de Jong Netherlands 33 2.4k 1.6× 750 0.7× 206 0.4× 1.0k 2.9× 226 0.7× 143 3.6k
Tatsuo Torizuka Japan 30 1.2k 0.8× 644 0.6× 638 1.2× 72 0.2× 487 1.5× 65 3.2k
Susanne Klutmann Germany 25 941 0.6× 750 0.7× 273 0.5× 80 0.2× 420 1.3× 98 2.0k
Motoomi Ohkawa Japan 28 903 0.6× 906 0.9× 336 0.6× 84 0.2× 488 1.5× 138 2.4k
U. Cremerius Germany 27 1.9k 1.2× 1.1k 1.0× 323 0.6× 139 0.4× 838 2.5× 47 3.3k
Oliver Dudeck Germany 25 654 0.4× 619 0.6× 138 0.3× 93 0.3× 485 1.4× 66 2.1k
K Endo Japan 27 965 0.6× 568 0.5× 206 0.4× 66 0.2× 267 0.8× 106 2.1k
Shingo Baba Japan 26 984 0.6× 499 0.5× 105 0.2× 132 0.4× 518 1.5× 142 2.5k
Mehrbod S. Javadi United States 32 1.8k 1.2× 1.3k 1.2× 439 0.8× 48 0.1× 315 0.9× 93 3.1k

Countries citing papers authored by Carl‐Martin Kirsch

Since Specialization
Citations

This map shows the geographic impact of Carl‐Martin Kirsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl‐Martin Kirsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl‐Martin Kirsch more than expected).

Fields of papers citing papers by Carl‐Martin Kirsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl‐Martin Kirsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl‐Martin Kirsch. The network helps show where Carl‐Martin Kirsch may publish in the future.

Co-authorship network of co-authors of Carl‐Martin Kirsch

This figure shows the co-authorship network connecting the top 25 collaborators of Carl‐Martin Kirsch. A scholar is included among the top collaborators of Carl‐Martin Kirsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl‐Martin Kirsch. Carl‐Martin Kirsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donazzan, Luca, Felix Mahfoud, Sebastian Ewen, et al.. (2015). Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension. Clinical Research in Cardiology. 105(4). 364–371. 45 indexed citations
2.
Schaefer, Andrea, Yoo Jin Kim, Stephanie Kremp, et al.. (2013). PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings. European Journal of Nuclear Medicine and Molecular Imaging. 40(8). 1233–1244. 31 indexed citations
3.
Grgic, Aleksandar, Jochen Fleckenstein, Stephanie Kremp, et al.. (2011). Impact of rigid and nonrigid registration on the determination of 18F-FDG PET-based tumour volume and standardized uptake value in patients with lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 38(5). 856–864. 5 indexed citations
4.
Grgic, Aleksandar, A Gröschel, Hans‐Joachim Schäfers, et al.. (2010). Risk stratification of solitary pulmonary nodules by means of PET using 18F-fluorodeoxyglucose and SUV quantification. European Journal of Nuclear Medicine and Molecular Imaging. 37(6). 1087–1094. 66 indexed citations
5.
Morschhauser, Franck, Françoise Kraeber‐Bodéré, William A. Wegener, et al.. (2010). High Rates of Durable Responses With Anti-CD22 Fractionated Radioimmunotherapy: Results of a Multicenter, Phase I/II Study in Non-Hodgkin's Lymphoma. Journal of Clinical Oncology. 28(23). 3709–3716. 78 indexed citations
6.
Grgic, Aleksandar, Ursula Nestle, Andrea Schaefer-Schuler, et al.. (2009). Nonrigid Versus Rigid Registration of Thoracic 18F-FDG PET and CT in Patients with Lung Cancer: An Intraindividual Comparison of Different Breathing Maneuvers. Journal of Nuclear Medicine. 50(12). 1921–1926. 17 indexed citations
7.
Suttmann, H., Aleksandar Grgic, Jan Lehmann, et al.. (2008). Combining 153 Sm-Lexidronam and Docetaxel for the Treatment of Patients with Hormone-Refractory Prostate Cancer: First Experience. Cancer Biotherapy and Radiopharmaceuticals. 23(5). 609–618. 15 indexed citations
8.
Grgic, Aleksandar, Ursula Nestle, Andrea Schaefer-Schuler, et al.. (2008). FDG-PET–Based Radiotherapy Planning in Lung Cancer: Optimum Breathing Protocol and Patient Positioning—An Intraindividual Comparison. International Journal of Radiation Oncology*Biology*Physics. 73(1). 103–111. 40 indexed citations
9.
Hellwig, D., Bernd Romeike, Ralf Ketter, et al.. (2007). Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas. European Journal of Nuclear Medicine and Molecular Imaging. 35(1). 24–31. 12 indexed citations
10.
Nestle, Ursula, Andrea Schaefer-Schuler, Stephanie Kremp, et al.. (2006). Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 34(4). 453–462. 70 indexed citations
11.
Hellwig, D., A Gröschel, Thomas Graeter, et al.. (2006). Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer. Eur J Nucl Med Mol Imaging. 18 indexed citations
12.
Samnick, Samuel, et al.. (2006). Preparation and tumor affinity testing of the radioiodinated tetrahydroisoquinoline derivative [123I]TIC(OH) for targeting prostate cancer. Applied Radiation and Isotopes. 64(5). 563–569. 4 indexed citations
13.
Samnick, Samuel, Bernd Romeike, Boris Kubuschok, et al.. (2004). p -[ 123 I]iodo-l-phenylalanine for detection of pancreatic cancer: basic investigations of the uptake characteristics in primary human pancreatic tumour cells and evaluation in in vivo models of human pancreatic adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 31(4). 532–541. 11 indexed citations
14.
Graeter, Thomas, D. Hellwig, Klaus H. Hoffmann, et al.. (2003). Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy. The Annals of Thoracic Surgery. 75(1). 231–236. 93 indexed citations
15.
Alexander, Christof, et al.. (2002). Localization of Extramedullary Hematopoiesis with Tc-99m–Labeled Monoclonal Antibodies (BW 250/183). Clinical Nuclear Medicine. 27(5). 354–357. 3 indexed citations
16.
Schwaab, Bernhard, G. Fröhlig, Christof Alexander, et al.. (1999). Influence of right ventricular stimulation site on left ventricular function in atrial synchronous ventricular pacing. Journal of the American College of Cardiology. 33(2). 317–323. 103 indexed citations
17.
Alexander, Christof, et al.. (1999). Monoclonal antibody MAb-170 for immunoscintigraphic detection of ovarian tumors. American Journal of Obstetrics and Gynecology. 181(3). 513–517. 6 indexed citations
18.
19.
Schnell, Oliver, Daniela Muhr, Carl‐Martin Kirsch, et al.. (1997). Three-year follow-up on scintigraphically assessed cardiac sympathetic denervation in patients with long-term insulin-dependent (type I) diabetes mellitus. Journal of Diabetes and its Complications. 11(5). 307–313. 15 indexed citations
20.
Tatsch, Klaus, Winfried A. Voderholzer, Martin J. Weiss, et al.. (1992). Simultaneous assessment of bolus transport and contraction parameters in multiple-swallow investigations.. PubMed. 33(7). 1291–300. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tohru Shiga Breakdown of academic impact, for papers by Hugo W. A. M. de Jong Breakdown of academic impact, for papers by Tatsuo Torizuka Breakdown of academic impact, for papers by Susanne Klutmann Breakdown of academic impact, for papers by Motoomi Ohkawa Breakdown of academic impact, for papers by U. Cremerius Breakdown of academic impact, for papers by Oliver Dudeck Breakdown of academic impact, for papers by K Endo Breakdown of academic impact, for papers by Shingo Baba Breakdown of academic impact, for papers by Mehrbod S. Javadi
Rankless by CCL
2026